NO924525L - Tri-arginininsuliner - Google Patents

Tri-arginininsuliner

Info

Publication number
NO924525L
NO924525L NO92924525A NO924525A NO924525L NO 924525 L NO924525 L NO 924525L NO 92924525 A NO92924525 A NO 92924525A NO 924525 A NO924525 A NO 924525A NO 924525 L NO924525 L NO 924525L
Authority
NO
Norway
Prior art keywords
arginininsuliner
tri
Prior art date
Application number
NO92924525A
Other languages
English (en)
Norwegian (no)
Other versions
NO924525D0 (no
Inventor
James Arthur Hoffmann
Peter Karl Lambooy
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO924525D0 publication Critical patent/NO924525D0/no
Publication of NO924525L publication Critical patent/NO924525L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO92924525A 1991-11-26 1992-11-24 Tri-arginininsuliner NO924525L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80116391A 1991-11-26 1991-11-26

Publications (2)

Publication Number Publication Date
NO924525D0 NO924525D0 (no) 1992-11-24
NO924525L true NO924525L (no) 1993-05-27

Family

ID=25180362

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92924525A NO924525L (no) 1991-11-26 1992-11-24 Tri-arginininsuliner

Country Status (17)

Country Link
US (2) US5491216A (cs)
EP (1) EP0544466A1 (cs)
JP (1) JP3304442B2 (cs)
KR (1) KR930009591A (cs)
CN (1) CN1072723A (cs)
AU (1) AU2857692A (cs)
BR (1) BR9204542A (cs)
CA (1) CA2083360A1 (cs)
CZ (1) CZ342492A3 (cs)
FI (1) FI925343A7 (cs)
HU (2) HUT63457A (cs)
IL (1) IL103849A0 (cs)
MX (1) MX9206724A (cs)
NO (1) NO924525L (cs)
NZ (1) NZ245170A (cs)
TW (1) TW224471B (cs)
ZA (1) ZA928916B (cs)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2289751T3 (es) * 1995-02-20 2008-02-01 The Walter And Eliza Hall Institute Of Medical Research Moleculas inmunorreactivas e inmunoterapeuticas que interaccionan en sujetos con diabetes mellitus insulinodependientes (dmid).
ATE264871T1 (de) * 1996-07-26 2004-05-15 Aventis Pharma Gmbh Insulinderivate mit erhöhter zinkbindung
US6444641B1 (en) 1997-10-24 2002-09-03 Eli Lilly Company Fatty acid-acylated insulin analogs
US6933272B1 (en) 1998-09-22 2005-08-23 Erik Helmerhorst Use of non-peptidyl compounds for the treatment of insulin related ailments
DE60120372T2 (de) 2000-03-24 2007-07-05 Genentech Inc., San Francisco Verwendung von insulin zur behandlung von knorpelkrankheiten
US20050014679A1 (en) * 2001-12-20 2005-01-20 Beals John Michael Insulin molecule having protracted time action
CA2518776A1 (en) * 2003-04-29 2004-11-11 Eli Lilly And Company Insulin analogs having protracted time action
WO2007081824A2 (en) * 2006-01-06 2007-07-19 Case Western Reserve University Fibrillation resistant proteins
WO2008015099A2 (en) 2006-07-31 2008-02-07 Novo Nordisk A/S Pegylated, extended insulins
AU2007298919C1 (en) 2006-09-22 2014-02-06 Novo Nordisk A/S Protease resistant insulin analogues
WO2008043033A2 (en) 2006-10-04 2008-04-10 Case Western Reserve University Fibrillation-resistant insulin and insulin analogues
US9387176B2 (en) 2007-04-30 2016-07-12 Novo Nordisk A/S Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein
CA2718738C (en) 2008-03-18 2019-05-07 Novo Nordisk A/S Protease stabilized, acylated insulin analogues
WO2009129250A2 (en) * 2008-04-14 2009-10-22 Case Western Reserve University Meal-time insulin analogues of enhanced stability
NZ588857A (en) * 2008-04-22 2012-07-27 Univ Case Western Reserve Isoform-specific insulin analogue for control blood sugar levels
US9200053B2 (en) 2008-07-31 2015-12-01 Case Western Reserve University Insulin analogues containing penta-fluoro-Phenylalanine at position B24
KR20120129875A (ko) 2008-07-31 2012-11-28 케이스 웨스턴 리저브 유니버시티 염소화 아미노산을 갖는 인슐린 유사체
US8399407B2 (en) * 2009-09-17 2013-03-19 Case Western Reserve University Non-standard insulin analogues
EP2509995A4 (en) 2009-12-11 2013-08-21 Univ Case Western Reserve INSULIN ANALOGUE WITH CHLORINATED AMINO ACIDS
US9187547B2 (en) * 2011-03-15 2015-11-17 Novo Nordisk A/S Human insulin analogues and derivatives comprising cysteine substitutions
US9481721B2 (en) 2012-04-11 2016-11-01 Novo Nordisk A/S Insulin formulations
WO2015052088A1 (en) 2013-10-07 2015-04-16 Novo Nordisk A/S Novel derivative of an insulin analogue
CN104017809A (zh) * 2014-06-05 2014-09-03 山东省农业科学院生物技术研究中心 改造的人Insulin蛋白表达基因及表达方法
US10392429B2 (en) 2014-10-06 2019-08-27 Case Western Reserve University Biphasic single-chain insulin analogues
CA2979397A1 (en) 2015-03-12 2016-09-15 Board Of Trustees Of Michigan State University Compositions and methods for measuring c-peptide binding and diagnosing immune-mediated diseases
US20180291077A1 (en) * 2015-09-24 2018-10-11 Hanmi Pharm. Co., Ltd Method of insulin production
ES2930149T3 (es) 2016-12-16 2022-12-07 Novo Nordisk As Composiciones farmacéuticas que contienen insulina

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
DE3326472A1 (de) * 1983-07-22 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
US4581165A (en) * 1984-06-14 1986-04-08 Eli Lilly And Company Anti-diabetic compounds
US4569792A (en) * 1984-06-14 1986-02-11 Eli Lilly And Company Anti-diabetic compounds
US4569791A (en) * 1984-06-14 1986-02-11 Eli Lilly And Company Anti-diabetic compounds
US5008241A (en) * 1985-03-12 1991-04-16 Novo Nordisk A/S Novel insulin peptides
DK129385A (da) * 1985-03-22 1986-09-23 Novo Industri As Peptider og fremstilling deraf
ZA877505B (en) * 1986-10-14 1989-05-30 Lilly Co Eli Process for transforming a human insulin precursor to human insulin
US4992418A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
ATE101620T1 (de) * 1988-06-23 1994-03-15 Hoechst Ag Mini-proinsulin, seine herstellung und verwendung.
DE3844211A1 (de) * 1988-12-29 1990-07-05 Hoechst Ag Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
DK134189D0 (da) * 1989-03-20 1989-03-20 Nordisk Gentofte Insulinforbindelser
DE3936876A1 (de) * 1989-11-06 1991-05-23 Hoechst Ag Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
US5130236A (en) * 1989-12-07 1992-07-14 Eli Lilly And Company Process for producing des(64,65)-proinsulin
US5139716A (en) * 1990-02-20 1992-08-18 Loral Aerospace Corp. Method of fabricating coolable ceramic structures

Also Published As

Publication number Publication date
US5698669A (en) 1997-12-16
NO924525D0 (no) 1992-11-24
BR9204542A (pt) 1993-06-01
NZ245170A (en) 1994-07-26
HU9203688D0 (en) 1993-03-29
HUT63457A (en) 1993-08-30
CN1072723A (zh) 1993-06-02
EP0544466A1 (en) 1993-06-02
FI925343L (fi) 1993-05-27
KR930009591A (ko) 1993-06-21
JP3304442B2 (ja) 2002-07-22
JPH05286998A (ja) 1993-11-02
ZA928916B (en) 1994-05-18
CZ342492A3 (en) 1993-06-16
FI925343A0 (fi) 1992-11-25
AU2857692A (en) 1993-05-27
CA2083360A1 (en) 1993-05-27
MX9206724A (es) 1993-05-01
IL103849A0 (en) 1993-04-04
FI925343A7 (fi) 1993-05-27
TW224471B (cs) 1994-06-01
US5491216A (en) 1996-02-13

Similar Documents

Publication Publication Date Title
DE69133396D1 (de) Warenauszahlsystem
DE69212332D1 (de) Farbball
DE59206583D1 (de) Windsichter
DE69219551D1 (de) Überrahmen
ATE137279T1 (de) Stoffauflauf
FI924978A0 (fi) Kaerna foer en elektriskt uppvaermbar katalytomvandlare
DE59209976D1 (de) Flaschendispenser
NO924525D0 (no) Tri-arginininsuliner
DE69219252D1 (de) Ölbehälter
BR9204511A (pt) Recolhedor-enrolador
DE59208716D1 (de) Lymphoides cd30-antigen
DE69232880D1 (de) Bittaktrückgewinnungsschaltung
DE59207013D1 (de) Sportschuh
DE69230668D1 (de) Imaginograph
FI933899A0 (fi) Heterocykliska foereningar
ATA170491A (de) Mauerstein
DE69232673D1 (de) Tiefsttemperaturmessausrüstung
ATE163916T1 (de) Ethyl-6-formyloxy-4-hexenoat
DE69220547D1 (de) 5-substituierte-2-Oxazolidinone
CA68725S (fr) Mobilier-jeu
PT8246T (pt) Cartao-tabuleiro
BR7101342U (pt) Hamburgueira
BR9105539A (pt) Cover-matelasse hospitalar
BR9104939A (pt) Fute-tenis
BR7100738U (pt) Aerofolio